These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21700075)

  • 21. Exophthalmos: a rare complication of systemic corticosteroids.
    Lobrano A; Pierce P; Harkins K
    J Miss State Med Assoc; 2002 Apr; 43(4):112. PubMed ID: 11989195
    [No Abstract]   [Full Text] [Related]  

  • 22. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect.
    Shah SK; Gecys GT
    J Am Osteopath Assoc; 2006 Nov; 106(11):653-7. PubMed ID: 17192452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
    Cuchacovich M; Solanes F; Díaz G; Cermenati T; Avila S; Verdaguer J; Verdaguer JI; Carpentier C; Stopel J; Rojas B; Traipe L; Gallardo P; Sabugo F; Zanoli M; Merino G; Villarroel F
    Ocul Immunol Inflamm; 2010 Jun; 18(3):200-7. PubMed ID: 20482399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.
    Zeitz J; Mullhaupt B; Fruehauf H; Rogler G; Vavricka SR
    Hepatology; 2009 Aug; 50(2):653-4. PubMed ID: 19575458
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug-induced pancreatitis associated with corticosteroids].
    Ouakaa-Kchaou A; Gargouri D; Elloumi H; Kochlef A; Romani M; Kilani A; Kharrat J; Ghorbel A
    Tunis Med; 2010 Feb; 88(2):137. PubMed ID: 20415182
    [No Abstract]   [Full Text] [Related]  

  • 27. Corticosteroids: severe psychiatric disorders.
    Prescrire Int; 2013 Mar; 22(136):73. PubMed ID: 23593698
    [No Abstract]   [Full Text] [Related]  

  • 28. [Psychiatric complications of glucocorticoid treatment].
    Suwalska A; Łojko D; Rybakowski J
    Psychiatr Pol; 2002; 36(2):271-80. PubMed ID: 12043044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical syndrome of the iatrogenic hypercorticoidism].
    Jasiński K; Witoszyński S
    Pol Arch Med Wewn; 1969 Aug; 43(2):1143-8. PubMed ID: 4242806
    [No Abstract]   [Full Text] [Related]  

  • 30. Prednisone for chronic obstructive pulmonary disease.
    Rolla G; Bucca C
    N Engl J Med; 2003 Sep; 349(13):1288-90; author reply 1288-90. PubMed ID: 14510015
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients.
    Tałałaj M; Gradowska L; Marcinowska-Suchowierska E; Durlik M; Gaciong Z; Lao M
    Transplant Proc; 1996 Dec; 28(6):3485-7. PubMed ID: 8962355
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adverse effects of glucocorticoids. Exacerbation of iatrogenic chronic adrenal failure in patient with acute coronary syndrome treated with glucocorticoids as a result of severe obstructive pulmonary disease. Case report].
    Andrys-Wawrzyniak I; Jabłecka A; Cieślewicz A; Korzeniowska K; Skołuda A
    Przegl Lek; 2010; 67(10):1093-5. PubMed ID: 21360969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
    Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
    Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central serous choroidopathy as rare complication of the corticosteroid treatment].
    Cepilová Z; Porubská M; Fabianová J
    Cesk Slov Oftalmol; 2009 Apr; 65(2):64-7. PubMed ID: 19408862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis.
    Lai HC; FitzSimmons SC; Allen DB; Kosorok MR; Rosenstein BJ; Campbell PW; Farrell PM
    N Engl J Med; 2000 Mar; 342(12):851-9. PubMed ID: 10727589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papillary muscle rupture complicating chronic steroid therapy.
    Marinella MA
    J Emerg Med; 2004 Jul; 27(1):89-90. PubMed ID: 15219313
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients.
    Olivieri O; Pizzolo F; Ravagnani V; Moretti L; Carletto A; Faccini G; Pasini F; Friso S; Corrocher R
    J Hypertens; 2008 Mar; 26(3):486-93. PubMed ID: 18300859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gast roduodenal complications of steroid and phenylbutazone therapy from the surgical viewpoint].
    Teutsch W
    Zentralbl Chir; 1968 Jul; 93(27):926-35. PubMed ID: 5666600
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychiatric hospitalisation across the life span].
    Lay B; Rössler W
    Neuropsychiatr; 2011; 25(2):67-74. PubMed ID: 21672505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.